Longboard Pharmaceuticals Inc

LBPH30 Nov 2024
Healthcare
$59.98
+0.00 (+0.03%)
Lowest Today
$59.98
Highest Today
$60.03
Today’s Open
$59.98
Prev. Close
$59.96
52 Week High
$60.03
52 Week Low
$3.82
To Invest in Longboard Pharmaceuticals Inc

Longboard Pharmaceuticals Inc

Healthcare
LBPH30 Nov 2024
+0.00 (+0.03%)
1M
3M
6M
1Y
5Y
Low
$59.98
Day’s Range
High
$60.03
59.98
52 Week Low
$3.82
52-Week Range
52 Week High
$60.03
3.82
1 Day
-
1 Week
+0.12%
1 month return
+0.48%
3 month return
+66.45%
6 month return
+234.57%
1 Year return
+1495.47%
3 Years return
+927.22%
5 Years return
-
10 Years return
-
Institutional Holdings
FMR Inc
11.15
Farallon Capital Management, L.L.C.
8.07
Cormorant Asset Management, LLC
7.15
T. Rowe Price Associates, Inc.
6.43
BlackRock Inc
6.07
Vanguard Group Inc
5.21
Viking Global Investors LP
5.05

Market Status

Fundamentals
Market Cap
2341.18 mln
PB Ratio
8.51
PE Ratio
0
Enterprise Value
2056.47 mln
Total Assets
50.7 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel and transformative medicines for neurological diseases. The company develops bexicaserin (LP352), which has completed Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. It also develops LP659, an S1P receptor modulator for the treatment of neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.
Organisation
Longboard Pharmaceuticals Inc
Employees
50
Industry
Biotechnology
CEO
Mr. Kevin R. Lind
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities